Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Diabetes

  • Article

    New Diabetes Medications and Holistic Management

    November 3, 2025

    Nearly one in four hospitalized 12patients in the U.S. has diabetes. These patients have almost twice the hospital readmission rate as those without diabetes, making it a critical area for...

  • Article

    Should We Use Non-Insulin Diabetic Agents on Inpatients?

    November 3, 2025

    Since endocrinologists proved they could name studies equally as well as cardiologists with the RABBIT 2 and NICE SUGAR trials, guidelines have recommended the use of insulin for inpatients with...

  • Article

    SGLT-2 Inhibitors’ Increased Risk of PAD-Related Surgical Events Compared to DPP-4 Inhibitors’ Risk When Used as Add-On Therapy in Diabetes

    October 1, 2025

    CLINICAL QUESTION: Do sodium-glucose cotransporter-2 (SGLT-2) inhibitors, as add-on therapy for diabetes, increase the risk of amputations, stent placement, or revascularization surgeries compared...

  • Article

    Managing Inpatient Diabetes: Practical Pearls and Complex Scenarios

    July 1, 2025

    In this high-yield session, Lily Ackermann, MD, a clinical associate professor of medicine at Thomas Jefferson University Hospital in Philadelphia, addressed the complexities of inpatient diabetes...

  • Article

    Effects of Semaglutide on CKD in Patients with Type 2 Diabetes: the FLOW Trial

    April 1, 2025

    Clinical question: Does treatment with semaglutide in patients with type 2 diabetes and chronic kidney disease (CKD) prevent the progression of CKD or death from kidney and cardiovascular...

  • Article

    There is a Decreased Risk of Hospitalization from Heart Failure in Type II Diabetics Initiated on a SGLT2 Inhibitor When Compared to a GLP-1 Receptor Agonist

    September 1, 2022

    Dr. Huang Clinical question: Determine the cardiovascular risk outcome in type II diabetic patients initiated on an sodium-glucose cotransporter-2 (SGLT2)  inhibitor versus a glucagon-like...

  • Article

    Many hospitalized patients with type 2 diabetes and mild hyperglycemia on admission can be managed with sliding scale insulin alone

    January 7, 2022

    Dr. Knees Clinical question: In patients with mild hyperglycemia on admission, can sliding scale insulin (SSI) alone be used for blood glucose (BG) control? Background: Prior randomized...

  • 1
    News

    Care via video teleconferencing can be as effective as in-person for some conditions

    December 6, 2021

    Video teleconferencing works best for monitoring patients with chronic conditions, according to the author of a new paper.

  • 1
    News

    SGLT2 inhibitor use tied to fewer atrial arrhythmias

    December 2, 2021

    A prospective study of nearly 14,000 patients who received an implantable cardiac device suggests that SGLT2-inhibitor treatment cuts atrial arrhythmias.

  • 1
    News

    Empagliflozin a winner in challenging arena of stabilized acute HF

    November 19, 2021

    Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.

1 2 3 … 14Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences